Copaxone and Arf - from FDA reports


Summary

Arf is found among people who take Copaxone, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Betaseron, and have Pain. This review analyzes which people have Arf with Copaxone. It is created by eHealthMe based on reports of 32,646 people who have side effects when taking Copaxone from FDA , and is updated regularly.

What to expect?

If you take Copaxone and have Arf, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Copaxone and have Arf

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 19, 2017

32,646 people reported to have side effects when taking Copaxone.
Among them, 82 people (0.25%) have Arf


Number of reports submitted per year:

Could Copaxone cause Arf?

Time on Copaxone when people have Arf *:

  • < 1 month: 23.08 %
  • 1 - 6 months: 61.54 %
  • 6 - 12 months: 15.38 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Arf when taking Copaxone *:

  • female: 75.31 %
  • male: 24.69 %

Age of people who have Arf when taking Copaxone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 7.55 %
  • 40-49: 28.3 %
  • 50-59: 32.08 %
  • 60+: 32.08 %

Top conditions involved for these people *:

  • Pain (6 people, 7.32%)
  • Diabetes (4 people, 4.88%)
  • Depression (4 people, 4.88%)
  • Urinary Incontinence (3 people, 3.66%)
  • Breast Cancer (3 people, 3.66%)

Top co-used drugs for these people *:

  • Betaseron (8 people, 9.76%)
  • Tysabri (7 people, 8.54%)
  • Avonex (7 people, 8.54%)
  • Ampyra (7 people, 8.54%)
  • Tecfidera (5 people, 6.10%)

Top other side effects for these people *:

  • Hypotension (10 people, 12.20%)
  • Loss Of Consciousness (9 people, 10.98%)
  • Urinary Tract Infection (8 people, 9.76%)
  • Dehydration (8 people, 9.76%)
  • Accidental Overdose (therapeutic Agent) (8 people, 9.76%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Arf when taking Copaxone?

Expand the study to include all drugs with the same ingredients

Arf and drugs with ingredients of glatiramer acetate.

Expand the study to include reports from both FDA and eHealthMe

Arf and Copaxone from FDA and eHealthMe reports

Copaxone

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 33,173 users)

Arf

Arf (acute renal failure (arf), is a rapid loss of kidney) has been reported by people with high blood pressure, multiple myeloma, coronary artery bypass, diabetes, rheumatoid arthritis (latest reports from 87,300 Arf patients).

Browse all side effects of Copaxone

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Arf

Arf

Could your condition cause Arf

Arf

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Copaxone and have Arf.

Questions to the study

More questions >

User reviews to the study

More reviews >